To specifically activate the 5-HT6R type without stimulating other types of 5-HT receptors that might be expressed in this neuroblastoma cell line, we applied a recently developed selective agonist of 5-HT6R, ST1936 [21]. Here, HTR6 is linked to neuroblastoma.